- Tytuł:
- Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)
- Autorzy:
- Źródło:
- In ESMO Open December 2021 6(6)
Czasopismo naukowe